Immediate Impact
2 by Nobel laureates 1 from Science/Nature 50 standout
Citing Papers
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
2024 Standout
Fluorescent Probes for Disease Diagnosis
2024 Standout
Works of Eileen Holmes being referenced
PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab
2016
Efficacy of Adjuvant Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer and Tumors ≤ 2 cm: A Meta-Analysis of the Randomized Trastuzumab Trials
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Eileen Holmes | 590 | 314 | 285 | 32 | 987 | |
| Duncan Wheatley | 716 | 360 | 325 | 56 | 1.0k | |
| Zsolt Gabos | 452 | 492 | 204 | 40 | 1.1k | |
| Marion Harris | 491 | 196 | 193 | 36 | 772 | |
| Leila T. Tchelebi | 410 | 344 | 178 | 40 | 956 | |
| Alessandra Felici | 475 | 351 | 192 | 49 | 1.1k | |
| Hubert Orfeuvre | 799 | 163 | 279 | 38 | 1.1k | |
| Penny J. Barnes | 333 | 169 | 261 | 44 | 823 | |
| Roger Allison | 444 | 188 | 96 | 28 | 1.1k | |
| V. Harvey | 806 | 197 | 506 | 22 | 1.1k | |
| Jianling Yuan | 361 | 211 | 355 | 39 | 1.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...